Clinical trial / 2009
Calcium supplementation during pregnancy lowered maternal blood lead levels in a randomized trial.
A randomized controlled trial evaluated 670 pregnant women in Mexico City assigned to 1,200 mg daily dietary calcium or placebo through pregnancy, with 557 completing follow-up. In intent-to-treat analysis, calcium supplementation was linked to an average 11% reduction (0.4 microg/dL, p = 0.004) in maternal blood lead compared to placebo. Decreases were most pronounced in compliant participants (-24%, p < 0.001) and during the second trimester (-14%, p < 0.001).
- Study type
- Randomized controlled trial
- Who was studied
- 670 pregnant women, Mexico City
- What was measured
- Maternal blood lead levels
THE PAPER
Effect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trial.
Ettinger AS, Lamadrid-Figueroa H, Téllez-Rojo MM, Mercado-García A, Peterson KE, Schwartz J, Hu H, Hernández-Avila M. Environ Health Perspect, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.